Pipex Pharmaceuticals acquires late-stage drug - MLive.com

Pipex Pharmaceuticals acquires late-stage drug MLive.com, MI - 12 hours ago Pipex (AMEX:PP) specializes in late-state drug candidates for the treatment of central nervous system and autoimmune diseases. Pipex Chief Executive Officer ...

Drug Makers’ Push Leads to Cancer Vaccines’ Fast Rise - BlueRidgeNow.com

Drug Makers’ Push Leads to Cancer Vaccines’ Fast Rise BlueRidgeNow.com, NC - 6 hours ago “We are a poor nonprofit, and I’ve been working on this issue for years,” said Mr. Kaye, who hopes to receive grants from the drug makers to help pay for ...

Why Should I Report an Adverse Drug Event? - RMGH Health News

Why Should I Report an Adverse Drug Event? RMGH Health News, CA - 8 hours ago This activity is supported by an independent educational grant from PhRMA. West Nile virus is a significant health threat. Transmitted by mosquitoes ...

Pipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate ... - MarketWatch

Pipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate ... MarketWatch - Aug 19, 2008 a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous system and autoimmune diseases, ...

Lpath Receives $6.4 Million Equity Financing - MarketWatch

Lpath Receives $6.4 Million Equity Financing MarketWatch - 2 hours ago Proceeds from the funding will be used to support the Phase 1 clinical trials for Lpath's two leading drug candidates, ASONEP(TM) and iSONEP(TM). ...